Abstract:Background Long‐term use of antiplatelet agents after acute coronary syndrome in diabetic patients is not well known. Here, we describe antiplatelet use and outcomes in such patients enrolled in the EPICOR Asia (Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia) registry. Methods and Results EPICOR Asia is a prospective, observational study of 12 922 patients with acute coronary syndrome surviving to discharge, from 8 countries/regions in Asia. The present analysis included 3162 patients with diabetes mellitus (DM) and 9602 patients without DM. The impact of DM on use of antiplatelet agents and events (composite of death, myocardial infarction, and stroke, with or without any revascularization; individual components, and bleeding) was evaluated. Significant baseline differences were seen between patients with DM and patients without DM for age, sex, body mass index, cardiovascular history, angiographic findings, and use of percutaneous coronary intervention. At discharge, ≈90% of patients in each group received dual antiplatelet therapy. At 2‐year follow‐up, more patients with DM tended to still receive dual antiplatelet therapy (60% versus 56%). DM was associated with increased risk from ischemic but not major bleeding events. Independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were age ≥65 years and use of diuretics at discharge. Conclusions Antiplatelet agent use is broadly comparable in patients with DM and patients without DM, although patients with DM are more likely to be on dual antiplatelet therapy at 2 years. Patients with DM are at increased risk of ischemic events, suggesting an unmet need for improved antithrombotic treatment. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01361386. Nonstandard Abbreviations and Acronyms DAPT dual antiplatelet therapy DM diabetes mellitus EPICOR Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients PoCE patient‐oriented composite end point Clinical Perspective What Is New? Among patients surviving an acute coronary syndrome, ≈90% of both patients with diabetes mellitus (DM) and patients without DM were discharged on dual antiplatelet therapy, but somewhat more patients with DM than patients without DM were on dual antiplatelet therapy at 2 years after discharge (60% versus 56%). Although DM was associated with increased risk of ischemic events during follow‐up, there was minimal impact on risk of major bleeding. Multivariable analysis showed that independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were older age (≥65 years) and use of diuretics at discharge. What Are the Clinical Implications? Despite a higher rate of dual antiplatelet therapy use in patients with DM than patients without DM at 2 years after an acute coronary syndrome, patients with DM were at increased risk of ischemic but not bleeding events, suggesting an unmet need for improved antithrombotic treatment. According to the International Diabetes Federation, in 2015, there were ≈415 million patients worldwide aged 20 to 79 with diabetes mellitus (DM), along with a further 193 million undiagnosed cases. 1 Type 2 DM accounts for up to 90% of all cases, and the prevalence is increasing globally. 1 About half of all deaths in patients with DM are due to cardiovascular disease, 1 the majority resulting from thrombotic events. 2 In addition, patients with DM have a 2‐ to 4‐fold higher risk of recurrent atherothrombotic events and vascular complications than those without DM. 2 Along with oxidative stress, inflam -Abstract Truncated-

Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality

The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes

Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014)

The prognostic effect of known and newly detected type 2 diabetes in patients with acute coronary syndrome

Impact of type 2 diabetes mellitus on recurrent myocardial infarction in China

Is Type 2 Diabetes Mellitus an Independent Risk Factor for Mortality in Hypertrophic Cardiomyopathy?

The impact of type 2 diabetes on short term myocardial morphological, functional, and energetic recovery post coronary artery bypass surgery in patients with ischemic heart disease

Short- and long-term mortality in patients with type 2 diabetes after myocardial infarction– a nationwide registry study

Impact of Diabetes Mellitus on the Outcomes of Patients with Acute Myocardial Infarction During Hospitalization

Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts

Worse Clinical Outcomes In Acute Myocardial Infarction Patients With Type 2 Diabetes Mellitus: Relevance To Impaired Endothelial Progenitor Cells Mobilization

Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction

Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.

Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes

Premature Mortality in Type 2 Diabetes Mellitus Associated with Heart Failure and Chronic Kidney Disease: 20 Years of Real-World Data

Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy

Association of risk factors on mortality in ST-elevation myocardial infarction patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies

Type 2 Diabetes Increases Risk of Unfavorable Survival Outcome for Postoperative Ischemic Stroke in Patients Who Underwent Non-cardiac Surgery: A Retrospective Cohort Study

Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry